UNSPSC 51391611: Aminophylline hydrate

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula 2C7H8N4O2.C2H8N2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y7E0LU9ZMS. European Medicines Agency schedules aminophylline hydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00461MIG. Most nations, for tariff and trade purposes, schedule aminophylline hydrate under HS 29395900. SMILES: CN1C2C(C(=O)N(C1=O)C)[NH]CN2.CN1C2C(C(=O)N(C1=O)C)[NH]CN2.C(CN)N.O.

UNSPSC 51391611 Aminophylline hydrate is a Commodity code nominally identifying a specific pharmaceutical product, but the recent state and local opportunities posted under this code do not procure aminophylline hydrate itself. Seminole County, Florida's IFB 60459723LAS solicits naloxone and safe drug deactivation systems—emergency opioid-reversal medications and equipment supporting community health initiatives—with annual quantities of 1,900 units of naloxone and 800 deactivation systems delivered quarterly to the county's Community Health Building in Sanford. The Texas Health and Human Services Commission's RFI HHS0017013, posted April 3, 2026, seeks vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, gathering market intelligence on establishing direct contracts between state pharmacy benefit programs and manufacturers to improve fulfillment efficiency and cost management. The issuing bodies include county health departments and state health and human services agencies focused on pharmaceutical procurement and distribution. The code shows minimal relevant recent activity—the two posted opportunities target pharmaceutical products and pharmacy program administration that do not match the aminophylline hydrate product specification implied by the code's nominal scope.

Geographic activity is limited to Florida and Texas based on the recent opportunities. Seminole County's IFB, posted June 30, 2026, with a due date of July 26, 2023 (note: the source contains a date inconsistency), is an open competitive bid requiring electronic submission through the county's e-Procurement Portal, with vendors responsible for all shipping and delivery costs; the contract term is two years with one-year renewal option and includes a three-month probationary termination clause. The Texas HHS RFI, with a response deadline of April 3, 2026, is exploratory—seeking vendor experience with direct contracting for self-insured employers and government health plans, value-based agreements, and fulfillment capacity outside traditional pharmacy benefit manager and group purchasing organization arrangements. This code does not reflect sustained state or local procurement activity for the pharmaceutical product it nominally names and warrants monitoring for clarity on actual commodity purchasing patterns versus code-tagging drift.